Kaj Johansson

Title: Kaj Johansson: Innovator in Immunomodulating Compounds

Introduction

Kaj Johansson is a notable inventor based in Helsingborg, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with immunomodulating activity. His work has led to the creation of innovative solutions that may have important applications in medicine.

Latest Patents

Kaj Johansson holds a patent for "Derivatives of quinoline-3-carboxanilide." This patent includes compounds characterized by the formula ##STR1##, where R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, and R.sup.7 can be selected from hydrogen, hydroxy, and methoxy. The compounds are designed to have immunomodulating activity, which could be beneficial in various therapeutic contexts. He has 1 patent to his name.

Career Highlights

Throughout his career, Kaj has been associated with Kabi Pharmacia Aktiebolag, a company known for its focus on pharmaceutical innovations. His work at the company has allowed him to explore and develop new compounds that contribute to advancements in healthcare.

Collaborations

Kaj Johansson has collaborated with notable colleagues such as Torbjorn Stalhandske and Karl-Erik Lundvall. These partnerships have likely enhanced the research and development processes, leading to more effective innovations in the pharmaceutical field.

Conclusion

Kaj Johansson's contributions to the field of immunomodulating compounds highlight his role as an important inventor in the pharmaceutical industry. His innovative work continues to pave the way for advancements in medical treatments.